Access to medicinal cannabis in Australia occurs through regulated healthcare pathways involving practitioner assessment, prescription requirements where applicable, and pharmacy dispensing systems.
Understanding these pathways can help patients navigate healthcare processes while recognising that clinical decisions remain the responsibility of qualified healthcare practitioners.
Medicinal cannabis products are prescription-only medicines in Australia.
Healthcare practitioners independently assess patient circumstances, healthcare history, current medications, and relevant clinical considerations before making healthcare decisions.
Additional information about practitioner-led assessment pathways is available through MOCA Health.
Telehealth services support healthcare communication across metropolitan, regional, and remote communities.
These systems help improve access to practitioner consultations while maintaining established healthcare standards.
Readers interested in healthcare communication systems may also review telehealth services for medicinal cannabis consultations.
Further educational resources include:
This page provides educational information only and should not be interpreted as medical advice. Consultation outcomes and prescribing decisions remain subject to practitioner assessment and Australian regulatory requirements.